Inventor · disambiguated record
Pierre-Henri Storck
Also filed as: STORCK PIERRE-HENRI
43 granted patents·11 pending applications·416 citations·filing 2004–2024
98Inventor score
Files withVERTEX PHARMA23JANSSEN PHARMACEUTICA NV9MERCK PATENT GMBH5CHARRIER JEAN-DAMIEN3STORCK PIERRE HENRI3
Top patents by PatentIndex Score
54 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0397US8912198B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Dec 16, 2014·20 cites·16 claims
- 0496US8957078B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Feb 17, 2015·19 cites·82 claims
- 0596US8841337B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted Sep 23, 2014·20 cites·10 claims
- 0695US9309250B2Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitorsSTORCK PIERRE-HENRI·Filed 2012·Granted Apr 12, 2016·22 cites·40 claims
- 0795US8853217B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted Oct 7, 2014·16 cites·15 claims
- 0894US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0994US8969360B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·25 cites·70 claims
- 1093US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 1193US8846686B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted Sep 30, 2014·16 cites·47 claims
- 1293US8822469B2Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinaseMACCORMICK SOMHAIRLE·Filed 2012·Granted Sep 2, 2014·22 cites·40 claims
- 1392US9670215B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·11 cites·3 claims
- 1490US9096602B2Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitorsEVERITT SIMON·Filed 2012·Granted Aug 4, 2015·20 cites·3 claims
- 1590US9062008B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jun 23, 2015·14 cites·2 claims
- 1690US8877759B2Aminopyrazines as ATR kinase inhibitorsCHARRIER JEAN-DAMIEN·Filed 2012·Granted Nov 4, 2014·16 cites·34 claims
- 1790US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1889US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 1989US8288377B2Inhibitors of the interaction between MDM2 and p53STORCK PIERRE-HENRI·Filed 2008·Granted Oct 16, 2012·23 cites·15 claims
- 2088US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 2188US8299256B2Quinolinone derivatives as PARP and TANK inhibitorsVIALARD JORGE EDUARDO·Filed 2008·Granted Oct 30, 2012·17 cites·9 claims
- 2287US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 2387US10800781B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 13, 2020·2 cites·18 claims
- 2486US8404713B2Quinolinone derivatives as PARP inhibitorsANGIBAUD PATRICK RENE·Filed 2008·Granted Mar 26, 2013·10 cites·14 claims
- 2584US10093676B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Oct 9, 2018·3 cites·19 claims
- 2684US7799772B2Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 21, 2010·16 cites·6 claims
- 2783US10793563B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 6, 2020·3 cites·28 claims
- 2882US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 2980US10988477B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Apr 27, 2021·3 cites·20 claims
- 3080US2025059190A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 3175US11583524B2Inhibitors of the interaction between MDM2 and P53JANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 21, 2023·0 cites·21 claims
- 3275US8778966B2Quinolinone derivatives as PARP and tank inhibitorsVIALARD JORGE EDUARDO·Filed 2012·Granted Jul 15, 2014·3 cites·6 claims
- 3372US9150540B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 6, 2015·1 cites·8 claims
- 3468US9573933B2Inhibitors of the interaction between MDM2 and P53PONCELET VIRGINIE SOPHIE·Filed 2008·Granted Feb 21, 2017·1 cites·12 claims
- 3568US8492377B2MTKI quinazoline derivativesPAPANIKOS ALEXANDRA·Filed 2007·Granted Jul 23, 2013·2 cites·15 claims
- 3667US8889866B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsAngibaud Patrick René·Filed 2009·Granted Nov 18, 2014·1 cites·8 claims
- 3762US12084438B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 3860US2018263966A1Inhibitors Of The Interaction Between MDM2 And P53JANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 3959US8933067B2Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·8 claims
- 4059US2022340577A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 4158US10208062B2Macrocyclic quinazole derivatives and their use as MTKIJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 19, 2019·0 cites·2 claims
- 4257US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4356US2017112818A1Inhibitors of the interaction between mdm2 and p53JANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 4453US9688691B2Macrocyclic quinazole derivatives and their use as MTKIJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 27, 2017·0 cites·25 claims
- 4552US2015376187A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4651US8853406B2Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53PONCELET ALAIN PHILIPPE·Filed 2008·Granted Oct 7, 2014·0 cites·9 claims
- 4751US8772272B2Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agentsFREYNE EDDY JEAN EDGARD·Filed 2010·Granted Jul 8, 2014·0 cites·3 claims
- 4851US2015291601A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4948US9598396B2Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 21, 2017·0 cites·2 claims
- 5046US2010152174A1Macrocyclic quinazole derivatives and their use as mtkiFREYNE EDDY JEAN EDGARD·Filed 2005·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →